Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Diabetes Mellitus, Adult-Onset

2,2'-azobis(2-amidinopropane) has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roche, M1
Tarnus, E1
Rondeau, P1
Bourdon, E1
Nagasaka, Y1
Kaku, K1
Nakamura, K1
Kaneko, T1
Haffner, SM1
Agil, A1
Mykkanen, L1
Stern, MP1
Jialal, I1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)[NCT00005146]0 participants Observational1979-05-31Completed
Incidence of Diabetes and Cardiovascular Disease in Mexican Americans[NCT00005205]0 participants Observational1987-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for 2,2'-azobis(2-amidinopropane) and Diabetes Mellitus, Adult-Onset

ArticleYear
Effects of nutritional antioxidants on AAPH- or AGEs-induced oxidative stress in human SW872 liposarcoma cells.
    Cell biology and toxicology, 2009, Volume: 25, Issue:6

    Topics: Adipocytes; Amidines; Animals; Antioxidants; Ascorbic Acid; Caffeic Acids; Cattle; Cell Line; Cell P

2009
The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro.
    Biochemical pharmacology, 1995, Sep-28, Volume: 50, Issue:7

    Topics: Administration, Oral; Amidines; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Li

1995
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Diabetes care, 1995, Volume: 18, Issue:5

    Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2;

1995
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Diabetes care, 1995, Volume: 18, Issue:5

    Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2;

1995
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Diabetes care, 1995, Volume: 18, Issue:5

    Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2;

1995
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Diabetes care, 1995, Volume: 18, Issue:5

    Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2;

1995